Surgimab SAS

Surgimab SAS is an SME in Montpellier, France that has taken part in 2 EU-funded projects since 2019, receiving €55k in EU funding.

EU funding received€55k
EU projects2
As coordinator0
Running now0
First EU project2019
Latest project2020
CountryFrance
EU registration (PIC)939099390
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Surgimab SAS's own share of each project, not the project's full budget.

  • Horizon 2020€55k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • PRISAR2Partner

    proactive monitoring of cancer as an alternative to surgery

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €55ktheir share
  • CASTPartner

    Active Monitoring of Cancer As An Alternative To Surgery

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • oncology
  • radiation chemistry
  • surgery
  • surgical procedures

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime